Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion
 
Yazarlar (13)
Nihat Şen Hatay Mustafa Kemal University
Mehmet Fatih Özlü
Yuksek Ihtisas Training & Research Hospital, Türkiye
Emin Özgür Akgül
Gulhane Training & Research Hospital, Türkiye
Selçuk Kanat
Sağlık Bilimleri Üniversitesi, Türkiye
Tuncer Çaycı
Gulhane Training & Research Hospital, Türkiye
Osman Turak Yuksek Ihtisas Training & Research Hospital
Halil Yaman Gulhane Training & Research Hospital, Türkiye
Prof. Dr. Erdoğan SÖKMEN Kırşehir Ahi Evran Üniversitesi, Türkiye
Fırat Özcan Yuksek Ihtisas Training & Research Hospital
Orhan Maden
Sağlık Bilimleri Üniversitesi, Türkiye
Ahmet Duran Demir Yuksek Ihtisas Training & Research Hospital
Adrıan Covıc C.I. Parhon University Hospital
Mehmet Kanbay Koç Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Atherosclerosis
Dergi ISSN 0021-9150 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI
Makale Dili İngilizce Basım Tarihi 11-2011
Kabul Tarihi 12-04-2026 Yayınlanma Tarihi
Cilt / Sayı / Sayfa 219 / 1 / 304–310 DOI 10.1016/j.atherosclerosis.2011.06.021
Makale Linki https://linkinghub.elsevier.com/retrieve/pii/S0021915011005028
Özet
OBJECTIVES We aimed to investigate the effects of admission asymmetric dimethylarginine (ADMA) levels on myocardial perfusion and prognosis in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). BACKGROUND ADMA, an endogenous inhibitor of endothelial nitric oxide synthase, was found to be elevated in plasma of patients with cardiovascular risk factors. METHODS 168 consecutive patients undergoing primary PCI for STEMI <12h after symptom onset and 75 healthy age and sex matched volunteer controls were enrolled in the study. Patients with STEMI were grouped into tertiles according to their admission plasma ADMA levels. Major adverse cardiac events during hospitalization or at one-year clinical follow-up were evaluated. Also angiographic impaired reperfusion was assessed by 3 different methods after PCI: angiographic …
Anahtar Kelimeler
Asymmetric dimethylarginine | ST segment elevation myocardial infarction | Percutaneous coronary intervention | Prognosis